drugset / Trial / NCT03990519
A Study of a Single Subcutaneous Dose of JNJ-26366821 in Healthy Participants
RandomizedSequentialTriple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability of a single subcutaneous (SC) dose of JNJ-26366821.
Timeline
- Start
- 2019-06-24
- Primary completion
- 2020-02-19
- Completion
- 2020-02-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RWJ-800088 | Unknown | — | Subcutaneous |
Indications
No indication recorded.